Cell mediated immune responses against human prion protein

Area of Science:

• Immunology
• Neuroscience
• Vaccinology

Background:

• Antibody-based strategies against prion diseases face challenges due to T cell tolerance to normal prion protein (PrPC) in wild-type mice.
• Generating effective immune responses against the abnormal prion protein (PrPSc) is crucial for developing therapeutic vaccines.
• Transgenic mouse models lacking PrPC expression offer a way to circumvent natural tolerance mechanisms.

Purpose of the Study:

• To investigate active prion protein (PrP)-specific T cell responses in PrP null (PrP 0/0) mice.
• To assess the feasibility of using simple peptide vaccination to induce T cell immunity against prions.
• To explore the potential of these T cell responses to overcome tolerance in wild-type mice.

Main Methods:

• Vaccination of PrP 0/0 mice with simple peptide procedures.
• In vitro analysis of spleenocytes for T cell proliferation and specificity.
• mRNA analysis to identify stimulated immune cell populations and cytokine profiles.
• T cell cloning to expand and characterize responsive T cells.

Main Results:

• Vaccinated PrP 0/0 mice exhibited significant T cell proliferative responses to prion peptides.
• mRNA analysis confirmed the stimulation of a heterogeneous T cell population with increased cytokine and cytotoxicity markers.
• Expanded T cell clones recognized mature human prion protein, indicating successful antigen-specific T cell activation.

Conclusions:

• Simple peptide vaccination can induce robust PrP-specific T cell responses in the absence of PrPC.
• These findings demonstrate a potential strategy to bypass T cell tolerance in prion disease research.
• The generated T cell clones may serve as a basis for developing novel therapeutic approaches for prion disorders.